While the pharmaceutical industry is relatively concentrated already, consolidation will continue in the future as companies struggle with high R&D costs and uncertain pipeline success rates. Drawing on its extensive experience guiding clients through uncertainty, and mergers and acquisitions, CAP partners with clients to ensure that executive compensation supports a successful close and integration process. CAP helps its pharmaceutical clients improve their ability to attract, retain, and motivate key executive talent in order to achieve their growth strategies. Learn more about CAP’s expertise in the pharmaceutical industry here or contact us for additional information.

Upcoming Events See All

Jun 25, 2024

2024 Proxy Season Review

New York, NY

A comprehensive review of the 2024 proxy season, exploring emerging trends, notable shareholder proposals, and regulatory developments. With a focus on corporate governance, executive…
  • Shaun Bisman
  • Chris Callegari